Journal
The Journal of clinical endocrinology & metabolism
Publication Date
10-18-2023
Volume
108
Issue
11
First Page
2990
Last Page
2998
Document Type
Open Access Publication
DOI
10.1210/clinem/dgad230
Rights and Permissions
Erik A Imel, Francis H Glorieux, Michael P Whyte, Anthony A Portale, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Pisit Pitukcheewanont, Etienne Sochett, Wolfgang Högler, Koji Muroya, Hiroyuki Tanaka, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, Mary Scott Roberts, Leanne M Ward, Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level, The Journal of Clinical Endocrinology & Metabolism, Volume 108, Issue 11, November 2023, Pages 2990–2998, https://doi.org/10.1210/clinem/dgad230. https://academic.oup.com/jcem/article/108/11/2990/7135936?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Recommended Citation
Imel, Erik A; Whyte, Michael P; Biggin, Andrew; and et al., "Burosumab vs phosphate/active vitamin D in pediatric X-linked hypophosphatemia: A subgroup analysis by dose level." The Journal of clinical endocrinology & metabolism. 108, 11. 2990 - 2998. (2023).
https://digitalcommons.wustl.edu/oa_4/4697
Department
ICTS (Institute of Clinical and Translational Sciences)